Author : Buchynska L.G.*
Molecular phenotype of high-grade endometrioid carcinoma of the endometriumAuthors :Buchynska L.G.* Glushchenko N.M. Nesina I.P. Brieieva O.V.... Date: 2020-12-24 / Views: 317
Overexpression of the mitochondrial ribosomal protein S18-2 in the invasive breast carcinomasAuthors :Buchynska L.G.* Iurchenko N.P. Kashuba E.V. Brieieva O.V.... Date: 2018-12-27 / Views: 368
Sensitivity to 4-hydroxyestradiol and DNA repair efficiency in peripheral blood lymphocytes of endometrial cancer patientsAuthors :Buchynska L.G.* Brieieva O.V.* Date: 2018-03-29 / Views: 342
Phenotypic features of endometrial tumors in patients with family history of cancerAuthors :Buchynska L.G.* Iurchenko N.P. Glushchenko N.M. Nesina I.P. Date: 2017-12-27 / Views: 293
The study of mismatch repair in endometrial cancer patients with a family history of cancerAuthors :Buchynska L.G.* Brieieva O.V. Nekrasov K.A. Nespryadko S.V. Vol. 37, No. 4 / Views: 433
FOXP3 gene promoter methylation in endometrial cancer cells
Authors :Buchynska L.G.* Iurchenko N.P. Verko N.P. Nekrasov K.A.... Vol. 37, No. 4 / Views: 757
Authors :Buchynska L.G.* Iurchenko N.P. Verko N.P. Nekrasov K.A.... Vol. 37, No. 4 / Views: 757
Comprehensive analysis of intratumoral lymphocytes and FOXP3 expression in tumor cells of endometrial cancerAuthors :Iurchenko N.P. Glushchenko N.M. Buchynska L.G.* Vol. 36, No. 4 / Views: 663
Mismatch repair proteins MSH2, MLH1 expression and DNA damage in tumor cells of endometrial cancer patients with family history of cancer
Authors :Brieieva O. Iurchenko N.P. Buchynska L.G.* Vol. 35, No. 2 / Views: 134
Authors :Brieieva O. Iurchenko N.P. Buchynska L.G.* Vol. 35, No. 2 / Views: 134
ANALYSIS OF p53, p16INK4A, pRB AND CYCLIN D1 EXPRESSION AND HUMAN PAPILLOMAVIRUS IN PRIMARY OVARIAN SEROUS CARCINOMAS
Authors :Buchynska L.G.* Pande N.T. Bilyk O.O. Vol. 33, No. 3 / Views: 769
Authors :Buchynska L.G.* Pande N.T. Bilyk O.O. Vol. 33, No. 3 / Views: 769
Different trends of p53, MDM2 and p14ARF expression patterns in endometrialadenocarcinomas versus hyperplasia
Authors :Buchynska L.G.* Nesina I.P. Kashuba E.V. 4 / Views: 72
Authors :Buchynska L.G.* Nesina I.P. Kashuba E.V. 4 / Views: 72
EXPRESSION OF p53, p21WAF1/CIP1, p16INK4A AND Ki-67 PROTEINS IN SEROUS OVARIAN TUMORS
Authors :Buchynska L.G.* Nesina I.P. Yurchenko N.P. Bilyk O.O.... Vol. 29, No. 1 / Views: 109
Authors :Buchynska L.G.* Nesina I.P. Yurchenko N.P. Bilyk O.O.... Vol. 29, No. 1 / Views: 109
CYTOGENETICAL INVESTIGATION OF TUMOR CELLS IN PATIENTS WITH OVARIAN AND ENDOMETRIAL CANCER
Authors :Polishchuk L.Z. Nesina I.P. Buchynska L.G.* Vorobyova L.I.... Vol. 25, No. 2 / Views: 22
Authors :Polishchuk L.Z. Nesina I.P. Buchynska L.G.* Vorobyova L.I.... Vol. 25, No. 2 / Views: 22
EXPRESSION OF THE CELL CYCLE REGULATORS p53, p21WAF1/CIP1 AND p16INK4A IN HUMAN ENDOMETRIAL ADENOCARCINOMA
Authors :Buchynska L.G.* Nesina I.P. 2 / Views: 100
Authors :Buchynska L.G.* Nesina I.P. 2 / Views: 100
Immunofluorescence staining of paraffin sections: creating DAB staining like virtual digital images using CMYK color conversion
Authors :Buchynska L.G.* Kashuba E. Szekely L. Vol. 30, No. 4 / Views: 305
Authors :Buchynska L.G.* Kashuba E. Szekely L. Vol. 30, No. 4 / Views: 305
Expression of the estrogen and progesterone receptors as prognostic factor in serous ovarian cancers
Author :Buchynska L.G.* Vol. 31, No. 1 / Views: 124
Author :Buchynska L.G.* Vol. 31, No. 1 / Views: 124